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ABSTRACT
Cancer is the second cause of death after cardiovascular diseases in the world. 
Anticancer prevention used can cause undesirable things. Flavonoids are secondary 
metabolites derived from natural products that are useful for anticancer treatment. 
This study was performed to observe the cytotoxic activity of alpinumisoflavone 
from Erythrina poeppigiana, toward cervical cancer (Hela), colon cancer (WiDr), 
and hepatoma cancer (HepG2) cells. The cytotoxic activity of alpinumisoflavone 
was tested using (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide) 
assay. The percentage of cell mortality was calculated and the IC50 was calculated 
using probit analysis. The result shown that alpinumisoflavone has antiproliferative 
effect to colon cancer (WiDr), cervical cancer (Hela), and hepatoma cancer (HepG2) 
cells with the value of IC50 are 5.63, 7.18, and 18.08 µg/ml, respectively. Based on 
the value of IC50 alpinumisoflavone is very cytotoxic to colon cancer WiDr cell.
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1. Introduction
Cancer is a very common problem with many ways 
of healing and prevention therapy. Chemotherapy is 
one of the many ways to prevent cancer, but it can 
cause a patient's health to decrease. Therefore, there 
is a focus on using alternative treatments and safe 
therapies against cancer. Medicinal plant species are 
already being used to treat or prevent development 
of cancer (Greenwell and Rahman 2015). 
Medicinal plants contain secondary metabolites 
with potential anticancer activities have been reported. 
The species Erythrina poeppigiana which is a family of 
Leguminosae and famous medicinal plants is used as a 
traditional medicine for anthelmintic, cancer, malaria, 
and inflammatory processes. Extracts of the leaves, 
stem bark, and roots of  E. poeppigiana  are known to 
contain secondary metabolites such as alkaloids and 
flavonoids (Herlina et al. 2018).
Previously, phytochemical analysis of E. poeppigiana 
has known the presence of erythrina alkaloids and 
isoflavonoids. Five isoflavonoids, erypogeins A, B, C, D, 
and E have been isolated from the roots of E. poeppigiana 
and eleven isoflavones  were isolated from the stem bark 
of E. poeppigiana (Tanaka et al. 2001, 2002; Herlina et al. 
2017). Purified flavonoids have also shown anticancer 
activities against other human cancers including; 
hepatoma (Hep-G2), cervical carcinoma (Hela), and 
breast cancer (MCF-7) (Greenwell and Rahman 2015). 
The affinity of isoflavonoids for the estrogen receptors 
ERα and ERβ was evaluated using a receptor binding 
assay (Djiogue et al. 2009). 
The cytotoxic activity of erypogein D from the stem 
bark of E. poeppigiana showed the highest activity (IC50 
30.12 M) against breast cancer MCF-7 cell compared 
to cervical cancer HeLa and ovarian cancer SKOV-3 
cells in vitro by using MTS assay method, this indicates 
that erypogein D belongs to the category of moderate 
cytotoxic activity (Herlina et al. 2017). Alpinumisoflavone 
compound (Figure 1) isolated from the stem bark of E. 
poeppigiana that has never been studied for cytotoxic 
activity. Thus, in this study, we reported the cytotoxic 
activity of alpinumisoflavone against cervical cancer 
(Hela), colon cancer (WiDr), and hepatoma cancer 
(HepG2) cells.
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Figure 1. The correlation 1H-1H COSY and  HMBC
= HMBC
2. Materials and Methods
2.1. Extraction and Isolation
The alpinumisoflavone was isolated from the 
stem bark of E. poeppigiana in the Organic Chemistry 
Laboratory, Universitas Padjadjaran, Indonesia. The 
dried powder of stem bark (2.4 kg) was extracted 
with methanol at room temperature for @ 3 x 24 h. 
The evaporated methanol extract (155.9 g) was then 
partitioned successively with n-hexane and ethyl acetate, 
to yield viscous concentrated of n-hexane (24.0 g) and 
ethyl acetate (30.0 g). The ethyl acetate extract (30.0 g) 
was fractionated by column chromatography on silica 
gel using a gradient n-hexane-ethyl acetate-methanol 
to give seven fractions (A–G). Fraction C (8.0 g) eluted 
with gradient of n-hexane/ethyl acetate (from 9:1 to 
100:0) was subjected to RF-18 column chromatography 
eluting with a gradient of methanol/water (from 8:2 
to 100:0) to obtain compound 1 (24 mg). 
 
2.2. Cell Culture (WiDr, HeLa, and HepG2) Cells
The HeLa, WiDr, and HepG2 cells were used to 
determine the cytotoxic activity of alpinumisoflavone. 
The HeLa (ATCC, CCL-2), WiDr (ATCC, HTB-77), and 
HepG2 (ATCC, HTB-22) cells were provided by the 
Faculty of Medicine Research Center, Universitas Gajah 
Mada, Yogyakarta. The WiDr and HeLa cell lines were 
maintained in DMEM (Gibco, 1195-065), 10% fetal 
bovine serum (FBS) (Gibco, 10270), and 1% Abam (Gibco, 
15240-062), while HepG2 cell lines were maintained in 
McCoy’s BA (Gibco, 16600-082), and added the same 
reagents for HeLa cell lines. HeLa, WiDr, and HepG2 
cells were secured under 37°C, 5% CO2 atmospheric, 
and 95% humidity. During an incubation time of 24 
hours, calculation of viable number of cells with the 
addition of Trypan blue staining and analyzed using 
haemocytometer (Widowati et al. 2013).
2.3. Cytotoxic Assay
Cytotoxic activity of alpinumisoflavone on the 
treated cells were determined using the (3-[4, 
5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium 
bromide) MTT colorimetric assay modified method. 
The treated cells culture (90 μl) of HeLa, WiDr, 
and HepG2 cells at density of 104 cells/well were 
distributed in 96-wells plates. Ten microlitres of the 
alpinumisoflavone at 100.0, 50.0, 25.0, 12.5, 6.25, and 
3.25 (μg/ml) was added to each well. Culture medium 
alone was served as negative control. The plate was 
then incubated for 24 h at 37°C in a 5% CO2. The mixture 
was further added with 20 μl of using MTT, incubated 
for 4 hours at 37°C in 5% of CO2. The absorbance was 
read at 490 nm wavelength (7). The cell growth 
inhibition was determined with the equation (2). % 
of cell growth inhibition=(OD of control cell-OD of 
treated cell)/(OD of control cell) x 100%. Inhibitory 
concentration (IC50) were determined using probit 
analysis. The IC50 values was obtained from average 
of three times independent experiments (Widowati 
et al. 2013).
3. Results
3.1. Analytical Data of Compound 1
Compound 1 as yellow crystal. Mp: 207-210oC; IR 
(KBr):3422, 2977, 1659, 1463, 1060, 800 cm-1; UV/Vis 
λmax (MeOH) nm (log ε):282 (4.27), 213 (4.53); HR-
TOFMS ES- spectrum showed [M+H]- 335.0877, calcd 
m/z 335.0861. The 1H NMR (600 MHz) and 13C NMR 
(150 MHz) spectroscopic data in CDCl3 (Table 1). 
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a= 150 MHz, b= 600 MHz, c = 125 MHz, and d=500 MHz
Pos. Compound 1
δCa (mult) δCc (mult)δHb (Int., mult.. J=Hz) δHd (Int., mult.. J=Hz)
  7.81 (1H, s)
         -
         -
         -
13.01 (1H,s)
        -
        -
  6.33 (1H, s)
        -
        -
  7.34 (1H, d, 7.8)
  6.84 (1H, d, 7.8)
        -
  6.84 (1H, d, 7.8)
  7.34 (1H, d, 7.8)
        -
  5.62 (1H, d, 9.6)
  6.71 (1H, d, 9.6)
  1.46 (6H, s)
7.78 (1H, s)
          -
          -
          -
13.07 (1H, s) 
          -
          -
6.30 (1H, s)
          -
          -
7.31 (1H, d, 8.1)
6.82 (1H, d, 8.1)
          -
6.82 (1H, d, 8.1)
7.31 (1H, d, 8.1)
          -
5.59 (1H, d, 10)
6.69 (1H, d, 10)
1.44 (6H, s)
152.7 (d)
123.7 (s)
181.1 (s)
106.2 (s)
156.9 (s)
105.7 (s)
159.7 (s)
  95.0 (d)
157.4 (s)
123.0 (s)
130.4 (d)
115.7 (d)
156.1 (s)
115.7 (d)
130.4 (d)
  78.2 (s)
128.3 (d)
115.5 (d)
  28.4 (d)
153.0 (d)
181.4 (s)
106.5 (s)
157.2 (s)
106.0 (s)
160.0 (s)
  95.3 (d)
156.5 (s)
124.0 (s)
130.7 (d)
116.1 (d)
157.7 (s)
116.1 (d)
130.7 (d)
  78.5 (s)
128.6 (d)
115.9 (d)
  28.7 (d)
Alpinumisoflavone
2
3
4
4a
5
6
7
8
8a
1'
2'
3'
4'
5'
6'
2"
3"
4"
2"-CH3
Table 1. 1H and 13C NMR spectroscopic data compound 1 and alpinumisolfavone in CDCl3
3.2. Cytotoxic Activity Compound 1 Against 
Colon Cancer (WiDr), Cervical Cancer (Hela), 
and Hepatoma Cancer (HepG2) Cells
The MTT method was used to determined of 
cytotoxic activity against WiDr, HeLa, and HepG2 cells. 
The results of cytotoxic activities are summarized in 
Table 2.
3.3. Morphological Appearance of  WiDr, HeLa, 
and HepG2 Cells
The morphological appearance of WiDr, HeLa, and 
HepG2 cells treated with compound 1 was showed in 
the Figure 2, 3, and 4.
4. Discussion
4.1. Characteristics of Compound 1
The UV absorption maxima of compound 1 in 
methanol were absorved at a peak 1 and 2 (287 and 
205 nm), which is characteristic of the carbonyl bound 
to a benzene group. The compound 1 was added AlCl3 
reactants showed bathochromic and hypochromic 
shift at a peak I and II (294 and 210 nm), indicating 
the formation of a compound AlCl3 complex between 
the hydroxyl and ketone groups, compound 1 is 
characteristic of isoflavone. Its IR spectrum showed 
absorption characteristic of hydroxyl and ketone 
aromatic (3422, 1659, and 1640 cm-1). 
The 1H NMR spectrum of compound 1 showed the 
presence of a signals typical of an isoflavone nucleus 
having a pyran ring. The 1H NMR spectrum revealed 
a pair of doublets (J=9.6 Hz) centered on δ 5.62 and 
6.71 and sharp singlets six proton intensities at 46 
1.46. The 1H NMR spectrum also displayed a pair of 
doublets (J=7.8 Hz), each integrating for two protons, 
at δ 6.84 and 7.34, which were assigned to the H-3΄ 
and H-5΄, and H-2΄ and H-6΄ of the para-disubstituted 
aromatic nucleus. The relatively upfield resonance (δ 
6.84) of H-3΄ and H-5΄ suggested the presence of an 
oxygenated substituent at C-4΄. The proton signal 
of hydroxyl group showed the presence of a broad 
singlet at δ 6.33 (1H), due to a hydroxyl group proton. 
These were assigned to a 2,2-dimethylchromene 
ring system. The characteristic C-2 proton of the 
isoflavone skeleton was evident as a singlet at δ 7.81 
(1H). 
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Table 2. The IC50 value of WiDr, HeLa, and HepG2 cells
Cells IC50 (μg/ml)
 5.63 
 7.18 
18.08
WiDr
HeLa
HepG2
WiDr cell
a b c d
Figure 2. Morphological appearance of WiDr cells with treatment of compound 1: (a) control, (b) 50.0, (c) 12.5, and (d) 
3.25 μg/ml. Scale bar: 40x
HeLa cell
a b c d
Figure 3. Morphological appearance of HeLa cells with treatment of compound 1: (a) control, (b) 50.0, (c) 12.5, and (d) 
1.56 μg/ml. Scale bar: 40x
The HMQC spectrum of compound 1 showed 
signal of H-2 (7.81) was bounded to an oxygenated 
carbon of C-2 (152.7), this was showed of compound 
1 is characteristic of isoflavone. The 1H-1H COSY 
spectrum of compound 1 showed the presence of a 
cross peak between H-2' (7.34) and H-3' (6.84), H-5' 
(6.84) and H-6' (7.34) indicated that the protons 
are ortho  position, and the crossing peaks between 
H-3" (5.62) and H-4" (4.71). The HMBC spectrum of 
compound 1 showed correlation of signal H-3' (6.84) 
with C-4' (156.1) and H-5' (6.84) with C-4' (156.1), 
indicated of hydroxyl group position at C-4'. The 
correlation of signal H-4" (6.71) with C-5 (156.9), 
indicated of hydroxyl group position at C-5. The 
correlation of signal proton (1.46) with C-7 (78.2) 
and C-2" showed of 2,2-dimethylpyran ring position 
(Figure 4). The 1H and 13C NMR spectroscopic data 
compound 1 and alpinumisoflavone in CDCl3 (Table 
1). On the basis of the above spectral data and by 
comparison of these values with those reported for 
alpinumisoflavone, C20H16O5. Alpinumisoflavone with 
another name is 5-hydroxy-7-(p-hydroxyphenyl)-
2,2-dimethyl-2H-6Hbenzo-[1,2-b:5,4-b]dipyran-6-
one (Hussaini et al. 2011). 
4.2. Cytotoxic Activity of Alpinumisoflavone
As shown in Table 2, alpinumisoflavone had the 
the lowest IC50 in colon cancer WiDr cell (5.63 μg/
ml) which indicated highest cytoxicity compared to 
cervical cancer cell (Hela) and hepatoma cancer cell 
(HepG2). Alpinumisoflavone is the most selective 
to colon cancer WiDr cell, however the cytotoxic 
activity of alpinumisoflavone is strong. 
Alpinumisoflavone as a major active ingredient 
commonly used as a traditional Chinese medicine 
Derris eriocarpa in Southwest part of China possesses 
a variety of pharmacological activities, including 
atheroprotective, estrogenic, and anti-bacterial 
(Wang et al. 2017). Alpinumisoflavone displayed 
cytotoxicity against the breast cancer MCF-7, lung 
cancer NCI-H18, and cervical cancer KB cells line with 
IC50 values of >100, >100, and 4.13 μM, respectively 
(Nkengfack et al. 2001; Sudanich et al. 2017). Effects 
of alpinumisoflavone on proliferation after 24, 48, 
and 72 h incubation of human leukemia U937 cell line 
showed IC50 values of 35, 32, and 28 μM, respectively 
(Matsuda et al. 2007). Alpinumisoflavone exhibited 
weak cytotoxic activity against the prostate cancer 
(PC3) cell line (Iranshahi et al. 2012). Wighteone 
and alpinumisoflavone isolated from E. indica 
(Leguminosae) showed cytotoxic activity against KB 
nasopharyngeal cancer cells, effective doses of 0.78 
and 4.13 μg/ml, respectively (Orang-ojong et al. 2013).
Alpinumisoflavone is a flavonoid that has a pyran 
ring as pyranisoflavonoid. Flavonoid pyran groups 
isolated from medicinal plants that are responsible 
as active substances. Alpinumisoflavone isolated 
from E. lysistemon of the African medicinal plant. 
Alpinumisoflavone reported as a treatment for 
the prevention of human lung tumor cell death 
(Namkoong et al. 2011). 
Flavonoid substituents shown growth inhibitory 
activity against cervical cancer (Hela) and colon 
cancer (WiDr) cells. The presence of hydroxyl group 
in A-ring in positions 5 also increase the cytotoxic 
activity of a flavonoids. The presence of hydroxyl 
group in B-ring in positions 4´ shown increase the 
cytotoxicity of a flavonoids. B-ring at heterocyclic C3 
position instead of C2 is characteristic of isoflavones. 
The study of cytotoxic activity of isoflavones showed 
high activity (López-Lázaro et al. 2002).
4.3. The Morphological Appearance
Based on the Figure 1 the morphological appearance 
of WiDr cell treated with alpinumisoflavone showed 
the decreasing of cell number, which indicate the 
effects of treatment toward WiDr cell cells growth. In 
the Figure 3 and 4, we can see that the morphological 
appearance of HeLa and HepG2 cells also showed the 
decreasing of cell number. Its indicate that treatment 
with alpinumisoflavone influence the cell growth of 
WiDr, HeLa, and HepG2. The result of present study 
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a b c d
Figure 4. Morphological appearance of HepG2 cells with treatment of compound 1: (a) control, (b) 50.0, (c) 12.5, and (d) 
1.56 μg/ml. Scale bar: 40x
HepG2  cell
suggests that the alpinumisoflavone might be a 
promising agent for anticancer treatment. 
5. Conclusion
Alpinumisoflavone compounds isolated from 
the stem bark of E. poeppigiana. Alpinumisoflavone 
showed the highest cytotoxic activity against colon 
cancer WiDr cell (5.63 μg/ml) compared with 
hepatoma cancer HepG2 and cervical cancer HeLa cells 
in vitro by MTT assay method. Alpinumisoflavone has 
a category of strong cytotoxic activity.
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